These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Seferović PM; Paulus WJ Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006 [TBL] [Abstract][Full Text] [Related]
5. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. Marwick TH; Ritchie R; Shaw JE; Kaye D J Am Coll Cardiol; 2018 Jan; 71(3):339-351. PubMed ID: 29348027 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy. Alonso N; Moliner P; Mauricio D Adv Exp Med Biol; 2018; 1067():197-217. PubMed ID: 28980272 [TBL] [Abstract][Full Text] [Related]
8. Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach. Dei Cas A; Spigoni V; Ridolfi V; Metra M Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):38-50. PubMed ID: 23369136 [TBL] [Abstract][Full Text] [Related]
9. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo. Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497 [TBL] [Abstract][Full Text] [Related]
10. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction. Lam CS Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570 [TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome in heart failure: insights to specific mechanisms. Gargiulo P; Marsico F; Renga F; Dell'Aversana S; Esposito I; Marciano C; Dellegrottaglie S; Perrone-Filardi P; Paolillo S Heart Fail Rev; 2020 Jan; 25(1):1-7. PubMed ID: 31414215 [TBL] [Abstract][Full Text] [Related]
13. The PKD inhibitor CID755673 enhances cardiac function in diabetic db/db mice. Venardos K; De Jong KA; Elkamie M; Connor T; McGee SL PLoS One; 2015; 10(3):e0120934. PubMed ID: 25798941 [TBL] [Abstract][Full Text] [Related]
14. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell. Khan S; Ahmad SS; Kamal MA Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531 [TBL] [Abstract][Full Text] [Related]
15. Diabetic cardiomyopathy--fact or fiction? Maisch B; Alter P; Pankuweit S Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347 [TBL] [Abstract][Full Text] [Related]
16. The limited clinical value of a specific diabetic cardiomyopathy. Vigili de Kreutzenberg S; Avogaro A Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):599-605. PubMed ID: 23725770 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota. Dandamudi S; Slusser J; Mahoney DW; Redfield MM; Rodeheffer RJ; Chen HH J Card Fail; 2014 May; 20(5):304-9. PubMed ID: 24576788 [TBL] [Abstract][Full Text] [Related]
18. Frequency of diabetic cardiomyopathy among type-2 diabetics presenting as heart failure. Muhammad Z; Hashmi A J Coll Physicians Surg Pak; 2013 Aug; 23(8):538-42. PubMed ID: 23930867 [TBL] [Abstract][Full Text] [Related]
20. Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy. Kim AH; Jang JE; Han J Biomed Pharmacother; 2022 Jan; 145():112463. PubMed ID: 34839258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]